Christopher Platta, MD
Radiation Oncology · Wausau, WINPI 1811127301
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Siemens Medical Solutions USA, Inc. accounts for 63.6% of it on its own, with 5 other manufacturers making up the rest.
Across 11 payments — averaging $62.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$437
- Myovant Sciences Inc.$125
- Varian Medical Systems, Inc.$82
- Johnson & Johnson$17
- Genentech USA, Inc.$14
- Merck$12
Across 7 payments — averaging $1450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$10K
What the payments were for
- Food & beverage$687100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 5 | $437 |
| Myovant Sciences Inc. | 1 | $125 |
| Varian Medical Systems, Inc. | 2 | $82 |
| Johnson & Johnson | 1 | $17 |
| Genentech USA, Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Varian IDENTIFY$133
- ORGOVYX$125
- Edge$105
How this compares
$687 in reported general payments places this provider in the 80th percentile of 131 radiation oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 118 | $307,791 |
| Oxycodone Hcl | 36 | $2,695 |
| Memantine Hcl ErMemantine Hcl | 20 | $1,259 |
| Tamsulosin Hcl | 99 | $967 |
| Omeprazole | 48 | $531 |
| Pilocarpine Hcl | 14 | $445 |
| Dexamethasone | 23 | $418 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $287 |
| SsdSilver Sulfadiazine | 12 | $267 |
| Bicalutamide | 19 | $265 |
| Lidocaine Hcl ViscousLidocaine Hcl | 20 | $228 |
| Gabapentin | 25 | $225 |
| Triamcinolone Acetonide | 13 | $223 |
| Nystatin | 13 | $200 |
| Fluconazole | 12 | $153 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Wausau
- Anna BrownWausau$9K
- Andrew HuangWausau$284
- Timothy KruserMadison$235K
- Stephen RosenbergMadison$18K
- Matthew WitekMadison$11K
- Joseph BoviMilwaukee$6K
- William HallMilwaukee$5K
- Jessica SchusterJohnson Creek$5K
- Lindsay PuckettMilwaukee$4K
- Douglas CalvinAppleton$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.